Feedback / Questions
berubicin (RTA 744) - CNS Pharma, WPD Pharma
https://www.prnewswire.com/news-releases/cns-pharmaceuticals-announces-fda-approval-of-ind-application-for-its-brain-cancer-drug-candidate-berubicin-301194766.html
Dec 17, 2020
SHARE THIS
Print
Email
More sharing
Reddit
StumbleUpon
Delicious
Prev
Next